These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Retinal blood flow levels measured by laser speckle flowgraphy in patients who received intravitreal bevacizumab injection for macular edema secondary to central retinal vein occlusion. Matsumoto M; Suzuma K; Fukazawa Y; Yamada Y; Tsuiki E; Fujikawa A; Kitaoka T Retin Cases Brief Rep; 2014; 8(1):60-6. PubMed ID: 25372211 [TBL] [Abstract][Full Text] [Related]
24. Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion. Pai SA; Shetty R; Vijayan PB; Venkatasubramaniam G; Yadav NK; Shetty BK; Babu RB; Narayana KM Am J Ophthalmol; 2007 Apr; 143(4):601-6. PubMed ID: 17306753 [TBL] [Abstract][Full Text] [Related]
25. Short-term efficacy of intravitreal triamcinolone acetonide for macular edema secondary to retinal vein occlusion that is refractory to intravitreal bevacizumab. Yoo SG; Kim JH; Lee TG; Kim CG; Kim JW Indian J Ophthalmol; 2015 Jan; 63(1):25-9. PubMed ID: 25686058 [TBL] [Abstract][Full Text] [Related]
26. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema due to central retinal vein occlusion. Wu WC; Cheng KC; Wu HJ Eye (Lond); 2009 Dec; 23(12):2215-22. PubMed ID: 19218991 [TBL] [Abstract][Full Text] [Related]
27. Herpetic Keratouveitis: Missed Diagnosis Leading to Corneal Perforation. Arun K; Georgoudis P Cureus; 2024 Mar; 16(3):e55471. PubMed ID: 38444929 [TBL] [Abstract][Full Text] [Related]
28. Six-month changes in cytokine levels after intravitreal bevacizumab injection for diabetic macular oedema and macular oedema due to central retinal vein occlusion. Wen J; Jiang Y; Zheng X; Zhou Y Br J Ophthalmol; 2015 Oct; 99(10):1334-40. PubMed ID: 25841235 [TBL] [Abstract][Full Text] [Related]
29. [Role of intravitreal bevacizumab for resistant macular edema due to central retinal vein occlusion after failure of intravitreal triamcinolone acetonide]. Le Moigne O; Duncombe A; Portmann A; Muraine M; Genevois O J Fr Ophtalmol; 2012 Nov; 35(9):700-4. PubMed ID: 22925843 [TBL] [Abstract][Full Text] [Related]
30. Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab. Papakostas TD; Lim L; van Zyl T; Miller JB; Modjtahedi BS; Andreoli CM; Wu D; Young LH; Kim IK; Vavvas DG; Esmaili DD; Husain D; Eliott D; Kim LA Eye (Lond); 2016 Jan; 30(1):79-84. PubMed ID: 26449196 [TBL] [Abstract][Full Text] [Related]
31. [Bevacizumab for the treatment of macular edema secondary to retinal vein occlusion]. Schaal KB; Höh AE; Scheuerle A; Schütt F; Dithmar S Ophthalmologe; 2007 Apr; 104(4):285-9. PubMed ID: 17372737 [TBL] [Abstract][Full Text] [Related]
32. Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial. Prager F; Michels S; Kriechbaum K; Georgopoulos M; Funk M; Geitzenauer W; Polak K; Schmidt-Erfurth U Br J Ophthalmol; 2009 Apr; 93(4):452-6. PubMed ID: 19074916 [TBL] [Abstract][Full Text] [Related]
33. Clinical outcome after switching therapy from ranibizumab and/or bevacizumab to aflibercept in central retinal vein occlusion. Pfau M; Fassnacht-Riederle H; Becker MD; Graf N; Michels S Ophthalmic Res; 2015; 54(3):150-6. PubMed ID: 26413794 [TBL] [Abstract][Full Text] [Related]
34. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion. Rosenfeld PJ; Fung AE; Puliafito CA Ophthalmic Surg Lasers Imaging; 2005; 36(4):336-9. PubMed ID: 16156153 [TBL] [Abstract][Full Text] [Related]
35. [Short-term effects of intravitreal injection of bevacizumab on macular edema due to central retinal vein occlusion]. Hayashi A; Ueta Y; Yunoki T; Mitarai K; Miyakoshi A; Takeda S; Fujita K; Watanabe K; Yanagisawa S; Kitagawa K Nippon Ganka Gakkai Zasshi; 2010 Apr; 114(4):347-55. PubMed ID: 20432959 [TBL] [Abstract][Full Text] [Related]
36. Rebound of macular edema after intravitreal bevacizumab therapy in eyes with macular edema secondary to branch retinal vein occlusion. Yasuda S; Kondo M; Kachi S; Ito Y; Terui T; Ueno S; Terasaki H Retina; 2011 Jun; 31(6):1075-82. PubMed ID: 21478810 [TBL] [Abstract][Full Text] [Related]
38. Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma. Batioğlu F; Astam N; Ozmert E Int Ophthalmol; 2008 Feb; 28(1):59-61. PubMed ID: 17609852 [TBL] [Abstract][Full Text] [Related]
39. Aflibercept Versus Bevacizumab and/or Ranibizumab for Recurrent Macular Edema Secondary to Central Retinal Vein Occlusion. Ozgonul C; Dedania VS; Besirli CG J Ocul Pharmacol Ther; 2018 May; 34(4):340-345. PubMed ID: 29447089 [TBL] [Abstract][Full Text] [Related]